<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02169843</url>
  </required_header>
  <id_info>
    <org_study_id>20140523 Dexmedetomidine</org_study_id>
    <nct_id>NCT02169843</nct_id>
  </id_info>
  <brief_title>Small Doses of Dexmedetomidine for Emergence Agitation</brief_title>
  <official_title>Influence of Small Doses Dexmedetomidine to the Elderly Patients' Emergence Agitation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tang-Du Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tang-Du Hospital</source>
  <brief_summary>
    <textblock>
      Dexmedetomidine Hydrochloride is a kind of high selectivity alpha 2 agonists adrenaline, can
      inhibit the activity of sympathetic nerve, and reduce the adverse effects of stress reaction
      in anesthesia recovery period.Literatures have been reported that Dex can reduce the rate of
      emergence agitation of children and adults,especially in elderly patients(&gt;64 years) after
      using sevoflurane anesthesia.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>May 2014</start_date>
  <completion_date type="Anticipated">October 2014</completion_date>
  <primary_completion_date type="Anticipated">October 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>evaluation of agitation</measure>
    <time_frame>the duration of PACU room stay,expect 30 minutes</time_frame>
    <description>stay in the PACU room after operation,measure the score of Aono's four-point scale(AFPS) every two minutes.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>evaluation of pain</measure>
    <time_frame>the duration of PACU room stay,expect 30 minutes</time_frame>
    <description>stay in the PACU room after operation,measure the score of numeric rating scale(NRS) every two minutes.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>the amount of drugs</measure>
    <time_frame>the duration of hospital stay,expect 5 weeks</time_frame>
    <description>when stay in the hospital,measure the total doses of Nalbuphine and Fentanyl using</description>
  </primary_outcome>
  <primary_outcome>
    <measure>number of agitation</measure>
    <time_frame>the duration of hospital stay,expect 5 weeks</time_frame>
    <description>when stay in the hospital, measure the number of agitation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>the mean arterial pressure</measure>
    <time_frame>from the beginning of induction to skin closure, up to 1 hour</time_frame>
    <description>measure the mean arterial pressure at 6 time points including after pump injection of Dexmedetomidine or normal saline 10 minutes, 20 minutes,30 minutes,before pulling out the endotracheal tube,at the time of pulling out the endotracheal tube,and after pulling out the endotracheal tube 5 minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>heart rate</measure>
    <time_frame>from the beginning of induction to skin closure, up to 1 hour</time_frame>
    <description>measure the heart rate at 6 time points including after pump injection of Dexmedetomidine or normal saline 10 minutes, 20 minutes,30 minutes,before pulling out the endotracheal tube,at the time of pulling out the endotracheal tube,and after pulling out the endotracheal tube 5 minutes</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Emergence Agitation</condition>
  <arm_group>
    <arm_group_label>Sevoflurane &amp; Dexmedetomidine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>inhale Sevoflurane + intravenous pumping Remifentanil 0.1µg/kg/min + intravenous inject cisatracurium besilate 0.08mg/kg in fixed time interval + finally add sufentanil 0.15µg/kg,and intravenous pumping Dexmedetomidine 0.2µg/kg/h.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sevoflurane &amp; Placebo</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>inhale Sevoflurane + intravenous pumping Remifentanil 0.1µg/kg/min + intravenous inject cisatracurium besilate 0.08mg/kg in fixed time interval + finally add sufentanil 0.15µg/kg,and intravenous pumping Placebo(for Dexmedetomidine )0.05ml/kg/h.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sevoflurane</intervention_name>
    <description>inhale Sevoflurane</description>
    <arm_group_label>Sevoflurane &amp; Dexmedetomidine</arm_group_label>
    <arm_group_label>Sevoflurane &amp; Placebo</arm_group_label>
    <other_name>Sevoflurome</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>intravenous pumping Dexmedetomidine 0.2µg/kg/h</description>
    <arm_group_label>Sevoflurane &amp; Dexmedetomidine</arm_group_label>
    <other_name>Dexmedetomidine Hydrochloride Injection</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo(for Dexmedetomidine)</intervention_name>
    <description>normal saline mimic Dexmedetomidine, intravenous pumping 0.05ml/kg/h</description>
    <arm_group_label>Sevoflurane &amp; Placebo</arm_group_label>
    <other_name>normal saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. obtain informed consent;

          2. patients whose selective under general anesthesia colorectal cancer or esophageal
             cancer radical operation time &gt; 2h;

          3. the American society of anesthesiologists (ASA) class I-II;

          4. age&gt;64 years old;

          5. BMI&lt;28kg/㎡;

        Exclusion Criteria:

          1. systolic pressure≥180mm Hg or&lt;90mm Hg, diastolic pressure≥110mm Hg or&lt; 60mm Hg;

          2. serious heart, brain, liver, kidney, lung, endocrine diseases or serious infections;

          3. patients with difficult airway (such as Mallampati airway class III, airway
             abnormalities, etc.)

          4. HR&lt;50times/min

          5. a history of mental illness or a long history of taking medicine of psychiatric drugs
             and chronic analgesics

          6. a history of alcoholism

          7. diseases of the neuromuscular

          8. a tendency to malignant hyperthermia

          9. allergy to test drugs or have other contraindications

         10. participated in other clinical drug researches over the past 30 days
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Meiyan Sun</last_name>
    <phone>15353575016</phone>
    <email>smyszdlz@126.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Tangdu Hospital</name>
      <address>
        <city>Xi'an</city>
        <state>Shanxi</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Meiyan Sun</last_name>
      <phone>15353575016</phone>
      <email>smyszdlz@126.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>June 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 26, 2014</study_first_submitted>
  <study_first_submitted_qc>June 19, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 23, 2014</study_first_posted>
  <last_update_submitted>June 19, 2014</last_update_submitted>
  <last_update_submitted_qc>June 19, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 23, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Dexmedetomidine,</keyword>
  <keyword>agitation,</keyword>
  <keyword>AFPS,</keyword>
  <keyword>NRS,</keyword>
  <keyword>mean arterial pressure</keyword>
  <keyword>heart rate(HR)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Psychomotor Agitation</mesh_term>
    <mesh_term>Emergence Delirium</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexmedetomidine</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

